Seeing Is Believing
Currently out of the existing stock ratings of Matt O'brien, 621 are a BUY (84.6%), 108 are a HOLD (14.71%), 5 are a SELL (0.68%).
Analyst Matt O'brien, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 65.3% that have a potential upside of 29.38% achieved within 172 days.
Matt O'brien’s has documented 1,597 price targets and ratings displayed on 54 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on STAA, STAAR Surgical Company at 12-Feb-2025.
Analyst best performing recommendations are on RMED (RA MEDICAL SYSTEMS).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 2/12/2025. The price target of $16 was fulfilled within 1 day with a profit of $5.88 (26.87%) receiving and performance score of 268.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$380
$-1.02 (-0.27%)
$235
2 years 3 months 18 days ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold
$388
$6.98 (1.83%)
$355
2 years 3 months 18 days ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold
$380
$-1.02 (-0.27%)
$350
2 years 3 months 19 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
$300
$-81.02 (-21.26%)
$425
2 years 4 months 7 days ago
(13-Oct-2022)
1/2 (50%)
$41.92 (16.24%)
19
Sell
$235
$-146.02 (-38.32%)
$275
2 years 7 months 5 days ago
(15-Jul-2022)
6/8 (75%)
$-33.23 (-12.39%)
143
Which stock is Matt O'brien is most bullish on?
Which stock is Matt O'brien is most reserved on?
What Year was the first public recommendation made by Matt O'brien?